GlassScriptPhysician profile
Okey Okoli
NPI 1215949144
$2,215.68
in general payments reported to CMS, 2019-2025
33 companies · $297 in 2025
The $297 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2020: $270 · 2021: $325 · 2022: $581 · 2023: $91.16 · 2024: $276 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $664.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $419.57 | 2019-2024 | |
| Fujirebio Diagnostics, Incorporated | $374.94 | 2022 | |
| Integra Lifesciences Corporation | $136.29 | 2019-2020 | |
| Applied Medical Resources Corporation | $112.51 | 2024 | Gelpoint V-Path |
| Coopersurgical, INC. | $111.88 | 2019-2025 | Paragard T 380a |
| Exeltis, USA INC. | $96.22 | 2019-2021 | |
| Biogen, INC. | $93.94 | 2024-2025 | Zurzuvae |
| Intuitive Surgical, INC. | $78.20 | 2025 | |
| Agile Therapeutics, INC. | $65.24 | 2021-2023 | Twirla |
| Ethicon US, LLC | $62.16 | 2021 | |
| Hologic Sales and Service, LLC | $55.46 | 2019-2021 | |
| Baxter Healthcare | $52.61 | 2025 | Perclot |
| Shield Therapeutics INC | $43.98 | 2022-2024 | Accrufer |
| Minerva Surgical, INC | $41.69 | 2025 | |
| Scynexis, INC. | $39.73 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $38.05 | 2023-2025 | Veozah, Myrbetriq |
| Lupin INC. | $37.05 | 2021 | |
| Mylan Pharmaceuticals INC. | $35.28 | 2020-2022 | |
| Becton, Dickinson and Company | $34.76 | 2024 | Bd Max System, Bd Max Instrument |
| Vertex Pharmaceuticals Incorporated | $33.34 | 2025 | |
| Avanos Medical | $25.21 | 2022 | |
| Roche Diagnostics Corporation | $25.05 | 2019 | |
| Myovant Sciences INC. | $23.57 | 2021 | |
| Mission Pharmacal Company | $22.54 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $21.74 | 2023 | |
| Therapeuticsmd, INC. | $20.06 | 2020 | |
| Sage Therapeutics, LLC | $19.77 | 2021 | |
| Pharmacosmos Therapeutics INC. | $19.24 | 2023 | Monoferric |
| Organon LLC | $18.07 | 2024 | |
| Pfizer INC. | $17.49 | 2024 | |
| Merck Sharp & Dohme LLC | $16.53 | 2019 | |
| Allergan, INC. | $13.27 | 2019 | |
| Meditrina | $10.24 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Okey Okoli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.